To reassess HNF4α heterogeneity in liver cancer, mouse and patient-derived human HCC and hepatoblastoma cell lines were first stained using an antibody recognizing both isoforms (P1 and P2) of HNF4α (Fig. 1a). Here, HNF4A is linked to hepatoblastoma.